NYSE:RCUS | Profit Breakdown | Arcus Biosciences, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$33M-$96M-$91M-$91M
2026-03-31$7M-$134M-$128M-$128M
2025-12-31$11M-$114M-$106M-$106M
2025-09-30$6M-$142M-$135M-$135M
2025-06-30$8M-$8M$0.00$0.00
2025-03-31$8M-$122M-$112M-$112M
2024-12-31$23M-$103M-$93M-$94M
2024-09-30$7M-$105M-$92M-$92M
2024-06-30$11M-$106M-$93M-$93M
2024-03-31$10M-$16M-$4M-$4M
2023-12-31-$49M-$91M-$80M-$81M
2023-09-30$32M-$80M-$69M-$71M
2023-06-30$29M-$83M-$74M-$75M
2023-03-31$25M-$86M-$78M-$80M
2022-12-31-$40M-$74M-$67M-$67M
2022-09-30$33M-$70M-$65M-$65M
2022-06-30$27M-$69M-$67M-$67M
2022-03-31$18M-$67M-$67M-$68M
2021-12-31$354.62M$281.02M$281.54M$279.54M
2021-09-30$9.46M-$78.14M-$77.98M-$77.98M
2021-06-30$9.46M-$76.14M-$75.97M-$75.97M
2021-03-31$9.46M-$72.75M-$72.59M-$72.59M
2020-12-31$9.97M-$51.78M-$52M
2020-09-30$64.53M$1.55M$1.82M
2020-06-30$1.75M-$45.38M-$45.07M
2020-03-31$1.75M-$28.4M-$27.75M
2019-12-31$9.75M-$17.53M-$16.6M
2019-09-30$1.75M-$23.25M-$22.35M
2019-06-30$1.75M-$29.16M-$28.09M
2019-03-31$1.75M-$18.77M-$17.67M
2018-12-31$1.56M-$13.48M-$12.3M
2018-09-30$4.29M-$12.15M-$10.81M
2018-06-30$1.25M-$15.9M-$13.53M
2018-03-31$1.25M-$13.33M-$12.96M
2017-12-31$1.25M-$13.34M-$13.21M
2017-09-30$163,000.00-$23.13M-$23.12M
2017-06-30-$9.66M-$9.55M
2017-03-31-$7.3M-$7.2M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$33M-$386M-$353M-$353M
2024-12-31$51M-$330M-$282M-$283M
2023-12-31$37M-$340M-$301M-$307M
2022-12-31$38M-$280M-$266M-$267M
2021-12-31$383M$54M$55M$53M
2020-12-31$78M-$124M-$123M-$123M
2019-12-31$15M-$88.71M-$84.71M-$84.71M
2018-12-31$8.35M-$54.86M-$49.59M
2017-12-31$1.41M-$53.44M-$53.08M
2016-12-31-$18.18M-$17.97M